Development and validation of an extended Cox prognostic model for patients with ER/PR+ and HER2− breast cancer: a retrospective cohort study

BACKGROUND: The purpose of this study was to explore a new estrogen receptor (ER) and/or progesterone receptor (PR)+ and human epidermal growth factor receptor 2 (HER2)− breast cancer prognostic model, called the extended Cox prognostic model, for determining the cutoff values for multiple continuou...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Yiqun, Li, Xizhou, Wu, Ying, Cui, Wenting, Liu, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555115/
https://www.ncbi.nlm.nih.gov/pubmed/36224558
http://dx.doi.org/10.1186/s12957-022-02790-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9555115/
https://www.ncbi.nlm.nih.gov/pubmed/36224558
http://dx.doi.org/10.1186/s12957-022-02790-0

Ejemplares similares